Akero Therapeutics, Inc

(NASDAQ:AKRO)

Latest On Akero Therapeutics, Inc (AKRO):

Date/Time Type Description Signal Details
2023-05-18 02:59 ESTNewsAkero Therapeutics: A Promising Solution For NASH Patients And InvestorsN/A
2023-05-17 13:48 ESTNewsAkero Therapeutics prices $220M offeringN/A
2023-05-15 20:39 ESTNewsAkero Therapeutics GAAP EPS of -$0.55N/A
2023-05-09 09:17 ESTNewsAkero Therapeutics: Proof Of Concept With EFX, Sets Up Catalyst Opportunities In 2023N/A
2023-05-07 19:00 ESTNewsAkero Therapeutics: Excellent Data, Solid Clinical Potential, No Major Near Term CatalystsN/A
2023-03-30 00:33 ESTNewsAkero plans to begin Phase 3 trial of NASH treatment in H2 after successful FDA meetN/A
2023-03-17 20:34 ESTNewsAkero Therapeutics GAAP EPS of -$0.49 beats by $0.31N/A
2023-02-08 18:19 ESTNewsAkero Therapeutics: NASH Differentiator Attractive, Awaiting Additional Price CatalystsN/A
2023-01-27 18:31 ESTNewsAkero upgraded at Morgan Stanley on NASH prospectsN/A
2022-12-08 21:25 ESTNewsAkero's liver disease drug gets FDA breakthrough therapy tagN/A
2022-11-24 02:08 ESTNewsAkero Therapeutics: What Is Making The Stock TickN/A
2022-11-04 15:25 ESTNewsAkero Therapeutics GAAP EPS of -$0.92 misses by $0.20N/A
2022-10-25 22:18 ESTNewsAkero: Putting Together The Pieces They Let Us SeeN/A
2022-09-19 18:37 ESTNewsAkero Therapeutics announces closing of upsized public offeringN/A
2022-09-19 02:04 ESTNewsAkero Therapeutics: A Promising NASH InnovatorN/A
2022-09-16 05:21 ESTNewsAkero Therapeutics: Outstanding Data In NASHN/A
2022-09-15 11:26 ESTNewsAkero Therapeutics stock slides on pricing upsized ~$200.0M stock offeringN/A
2022-09-14 18:07 ESTNewsAkero Therapeutics' Positive NASH Trial Results And Cash RaiseN/A
2022-09-14 00:37 ESTNewsAkero stock soars 71% as drug improves liver fibrosis, prevents disease worsening in trialN/A
2022-09-14 00:36 ESTNewsAkero adds over 100% rallying peers after NASH successN/A
2022-09-14 00:36 ESTNewsAkero Therapeutics commences underwritten public offering of $175M of sharesN/A
2022-08-04 23:03 ESTNewsAkero Therapeutics GAAP EPS of -$0.77 beats by $0.10N/A
2022-06-16 14:38 ESTNewsPfizer makes $25M equity investment in AkeroN/A
2022-05-06 18:49 ESTNewsAkero Therapeutics GAAP EPS of -$0.74 beats by $0.07N/A
2022-02-25 22:21 ESTNewsAkero Therapeutics GAAP EPS of -$0.93 misses by $0.13N/A
2022-02-09 07:08 ESTNewsAkero finishes enrollment in phase 2b trial of efruxifermin in liver diseaseN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Investor Presentation - SlideshowN/A
2021-11-12 16:26 ESTNewsAkero Therapeutics EPS beats by $0.16N/A
2021-10-20 02:11 ESTNewsAkero nabs Fast Track designation for efruxifermin for NASHN/A
2021-10-12 20:08 ESTNewsWarning: AKRO is at high risk of performing badlyN/A
2021-10-07 04:15 ESTNewsAKRO is at high risk of performing badlyN/A
2021-09-27 12:22 ESTNewsWarning: AKRO has been downgraded to Very BearishN/A
2021-09-23 22:19 ESTNewsAkero: Ticking All The Right Boxes In NASHN/A
2021-09-22 20:56 ESTNewsWarning: AKRO has been downgraded to Very Bearish.N/A
2021-09-10 16:11 ESTNewsAkero initiated with a buy at BofA on underappreciated clinical profileN/A
2021-08-13 08:25 ESTNewsAkero Therapeutics EPS misses by $0.17N/A
2021-07-20 18:14 ESTNewsAkero Therapeutics' efruxifermin meets primary endpoint in mid-stage NASH trialN/A
2021-07-20 18:08 ESTNewsAkero Therapeutics adds Judy Chou to its board of directorsN/A
2021-04-21 13:38 ESTNews89bio could close the valuation gap with Akero by end of 2021: CantorN/A
2021-03-18 12:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $59.5 to $58.75.Neutral
2021-03-17 20:05 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$3.73 is estimated for the 2022 year.Sell
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$0.80 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-16 18:57 ESTNewsAkero Therapeutics EPS misses by $0.29N/A
2021-03-01 11:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $60.29 to $59.5.Neutral
2020-12-13 03:07 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:04 ESTFinancialsCompany financials have been released.Neutral

About Akero Therapeutics, Inc (AKRO):

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

AKRO Quotes by TradingView

See Advanced Chart

General

  • Name Akero Therapeutics, Inc
  • Symbol AKRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 13
  • Fiscal Year EndDecember
  • IPO Date2019-06-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.akerotx.com
View More

Valuation

  • Trailing PE 8.18
  • Price/Book (Most Recent Quarter) 4.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.88
  • Next Year EPS Estimate -$4.26
  • Next Quarter EPS Estimate -$0.55
  • Return on Assets -18%
  • Return on Equity -30%
  • Earnings Per Share -$91.75
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.11 billion
  • Analyst Target Price $58.75
  • Book Value Per Share $8.25
View More

Share Statistics

  • Shares Outstanding 34.77 million
  • Shares Float 17.06 million
  • % Held by Insiders 840%
  • % Held by Institutions 93.8%
  • Shares Short 2.23 million
  • Shares Short Prior Month 2.13 million
  • Short Ratio 9.66
  • Short % of Float 12%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $41.16
  • 52 Week Low $15.02
  • 50 Day Moving Average 31.18
  • 200 Day Moving Average 29.64
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Akero Therapeutics, Inc (AKRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Akero Therapeutics, Inc (AKRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.86-$0.59-45.76%
2020-09-302020-11-12$N/A-$0.63-$0.676.11%
2020-06-302020-08-12$N/A-$0.57-$0.627.72%
2020-03-312020-05-13$N/A-$0.42-$0.6131.15%
2019-12-312020-03-16$N/A-$0.55-$0.585.97%
2019-09-302019-11-12$N/A-$0.56-$0.43-30.69%
2019-06-302019-08-12$N/A-$0.26-$0.3628.51%

Akero Therapeutics, Inc (AKRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 25.71 million 17.38 million 13.04 million 8.79 million 13.14 million
Income Before Tax -29.71 million -21.4 million -16.21 million -11.89 million -15.61 million
Selling General Administrative 4.07 million 4.16 million 3.42 million 3.59 million 3.08 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -29.77 million -21.54 million -16.45 million -12.38 million -16.22 million
Operating Income -29.78 million -21.54 million -16.45 million -12.38 million -16.22 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net 72000 N/A N/A N/A 610000
Net Income From Continuing Operations -29.71 million -21.4 million -16.21 million -11.89 million -15.61 million
Net Income Applicable to Common Shares -29.71 million -21.4 million -16.21 million N/A -15.61 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -59.84 million 38.47 million -6.28 million N/A N/A
Change to Liabilities 2.1 million 1 million N/A N/A -1.6 million
Total Cash Flow from Investing Activities -59.84 million 38.47 million N/A N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 202.78 million 100000 164000 N/A -1.61 million
Change to Operating Activities 4.18 million -8.8 million N/A N/A 3.46 million
Change in Cash 129.43 million 15.98 million -17.43 million N/A -14.82 million
Total Cash from Operating Activities -13.51 million -22.58 million -11.32 million N/A -13.21 million
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities 67000 -67000 N/A N/A N/A
Change to Net Income 1.61 million 1.42 million N/A N/A 483000
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 14.63 million 13.58 million 10.4 million 8.3 million 9.39 million
Total Stockholder Equity 258.71 million 286.46 million 103.66 million 118.32 million 128.73 million
Other Current Liabilities 13.11 million 126000 146000 126000 9.37 million
Total Assets 273.34 million 300.04 million 114.06 million 126.62 million 138.12 million
Common Stock 258.71 million 4000 3000 N/A 128.73 million
Other Current Assets 2.96 million N/A N/A N/A 1.65 million
Retained Earnings -209.53 million -179.82 million -158.41 million -142.21 million N/A
Other Liabilities N/A N/A 2000 N/A 23000
Other Assets 1.99 million 156000 865000 N/A 69000
Cash 187.24 million 192.68 million 63.25 million 47.25 million 136.4 million
Total Current Liabilities 13.11 million 12.01 million 10.39 million 8.29 million 9.37 million
Other Stockholder Equity N/A 16000 90000 N/A N/A
Property, Plant & Equipment N/A 1.85 million N/A N/A N/A
Total Current Assets 271.35 million 298.03 million 113.19 million 126.22 million 138.05 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 258.71 million 286.46 million 103.66 million N/A 128.73 million
Short Term Investments 81.15 million 99.19 million 39.59 million 78.04 million N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 3.43 million 4.64 million 2.54 million 1.54 million N/A

Akero Therapeutics, Inc (AKRO) Chart:

Akero Therapeutics, Inc (AKRO) News:

Below you will find a list of latest news for Akero Therapeutics, Inc (AKRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Akero Therapeutics, Inc (AKRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-10-17250CALL0 0169.5TRUE00
2025-10-1727.50CALL0 0145.25TRUE00
2025-10-17300CALL0 0132TRUE00
2025-10-1732.50CALL0 0117.02TRUE00
2025-10-17350CALL0 073.82TRUE00
2025-10-1737.57.2CALL0 176TRUE00
2025-10-17405.04CALL0 166.66TRUE00
2025-10-1742.59.7CALL0 463.29TRUE00
2025-10-17453.14CALL0 31958.8TRUE00
2025-10-1747.52.74CALL0 9053.01FALSE00
2025-10-17501CALL0 567129.47FALSE00
2025-10-1752.51.16CALL0 40141.17FALSE00
2025-10-17550.25CALL0 272152.62FALSE00
2025-10-1757.51.8CALL0 1166.53FALSE00
2025-10-17600.15CALL0 92178.72FALSE00
2025-10-17650.06CALL36 986.85FALSE-0.04-0.4
2025-10-17700CALL0 0228.62FALSE00
2025-10-17250PUT0 0355.38FALSE00
2025-10-1727.50PUT0 0313.31FALSE00
2025-10-17300PUT0 0274.82FALSE00
2025-10-1732.50PUT0 0239.1FALSE00
2025-10-17350PUT0 0205.5FALSE00
2025-10-1737.50.6PUT0 157175.38FALSE00
2025-10-17400.5PUT0 11129.43FALSE00
2025-10-1742.51.03PUT0 38079.15FALSE00
2025-10-17452.2PUT0 7559.17FALSE00
2025-10-1747.52.77PUT0 857.07TRUE00
2025-10-17505.7PUT0 761.48TRUE00
2025-10-1752.50PUT0 065.07TRUE00
2025-10-17550PUT0 074.35TRUE00
2025-10-1757.50PUT0 080.31TRUE00
2025-10-176012.51PUT0 00TRUE00
2025-10-17650PUT0 00TRUE00
2025-10-17700PUT0 00TRUE00
2025-11-21200CALL0 0113.05TRUE00
2025-11-2122.50CALL0 096.1TRUE00
2025-11-212523.95CALL0 188.68TRUE00
2025-11-2127.50CALL0 084.84TRUE00
2025-11-213019.41CALL0 475.19TRUE00
2025-11-2132.50CALL0 075.11TRUE00
2025-11-21350CALL0 070.75TRUE00
2025-11-2137.510.1CALL0 167.87TRUE00
2025-11-214011.4CALL0 4066.07TRUE00
2025-11-2142.59.3CALL0 1065.21TRUE00
2025-11-21455.55CALL1 38473.99TRUE0.670.14
2025-11-2147.54CALL1 15067.53FALSE40
2025-11-21502.7CALL0 62973.22FALSE00
2025-11-2152.52.5CALL0 8272.16FALSE00
2025-11-21551.74CALL2 14457.78FALSE1.740
2025-11-2157.50.9CALL28 536459.01FALSE0.90
2025-11-21600.57CALL0 27059.15FALSE00
2025-11-2162.50.55CALL0 71108.73FALSE00
2025-11-21650.5CALL0 146113.18FALSE00
2025-11-21700.4CALL0 1629122.22FALSE00
2025-11-21751.05CALL0 136131.52FALSE00
2025-11-21800.45CALL0 47140.61FALSE00
2025-11-21200PUT0 0237.55FALSE00
2025-11-2122.50PUT0 0210.09FALSE00
2025-11-21250PUT0 0185.79FALSE00
2025-11-2127.50PUT0 0165.38FALSE00
2025-11-21300.5PUT0 8147.92FALSE00
2025-11-2132.50.7PUT0 30132.64FALSE00
2025-11-21351.45PUT0 44121.1FALSE00
2025-11-2137.51.85PUT0 112112.14FALSE00
2025-11-21401.87PUT0 95263.34FALSE00
2025-11-2142.53.3PUT0 4573.94FALSE00
2025-11-21453.34PUT0 35769.43FALSE00
2025-11-2147.55.39PUT0 7959.07TRUE00
2025-11-21507PUT0 37158.53TRUE00
2025-11-2152.58.3PUT0 2956.83TRUE00
2025-11-21559.4PUT0 14356TRUE00
2025-11-2157.510.16PUT0 5956.12TRUE00
2025-11-216012.3PUT0 14257.47TRUE00
2025-11-2162.511.9PUT0 3656.09TRUE00
2025-11-216514.8PUT0 1055.53TRUE00
2025-11-21700PUT0 065.05TRUE00
2025-11-21750PUT0 00TRUE00
2025-11-21800PUT0 00TRUE00
2026-01-162.50CALL0 0256.9TRUE00
2026-01-1650CALL0 00TRUE00
2026-01-167.50CALL0 0153.9TRUE00
2026-01-16100CALL0 0135.21TRUE00
2026-01-1612.50CALL0 4109.81TRUE00
2026-01-16150CALL0 1107.25TRUE00
2026-01-1617.50CALL0 6996.01TRUE00
2026-01-162032CALL0 881.1TRUE00
2026-01-1622.50CALL0 1080.14TRUE00
2026-01-162525CALL0 2676.11TRUE00
2026-01-1627.521.85CALL0 1170.8TRUE00
2026-01-163020.3CALL0 22170.3TRUE00
2026-01-1632.50CALL0 1669.35TRUE00
2026-01-163514.17CALL0 1866.31TRUE00
2026-01-1637.519.38CALL0 6066.15TRUE00
2026-01-164010.45CALL0 5871.3TRUE00
2026-01-1642.59.45CALL0 7765.31TRUE00
2026-01-16457.87CALL0 5366.31TRUE00
2026-01-1647.57CALL0 97262.57FALSE00
2026-01-16504.4CALL102 68258.44FALSE00
2026-01-1652.54.2CALL0 3756.07FALSE00
2026-01-16552.55CALL0 7160.54FALSE00
2026-01-1657.51.75CALL0 3051.23FALSE00
2026-01-16602.05CALL0 10781.32FALSE00
2026-01-1662.52.69CALL0 784.59FALSE00
2026-01-16651.24CALL0 13086.25FALSE00
2026-01-16700.35CALL0 37589.93FALSE00
2026-01-16751.22CALL0 25794.03FALSE00
2026-01-16800.19CALL0 50099.06FALSE00
2026-01-16851.02CALL0 4118.51FALSE00
2026-01-162.50PUT0 0781.66FALSE00
2026-01-1650PUT0 15201.36FALSE00
2026-01-167.50PUT0 0340.82FALSE00
2026-01-16100PUT0 0282.12FALSE00
2026-01-1612.50PUT0 15240.98FALSE00
2026-01-16150PUT0 0209.41FALSE00
2026-01-1617.50PUT0 2183.8FALSE00
2026-01-16200.05PUT0 169163.61FALSE00
2026-01-1622.50PUT0 1146.03FALSE00
2026-01-16250.45PUT0 57110.46FALSE00
2026-01-1627.50.7PUT0 2121.14FALSE00
2026-01-16301.25PUT0 47111.16FALSE00
2026-01-1632.51.65PUT0 5104.6FALSE00
2026-01-16351.9PUT0 3470.57FALSE00
2026-01-1637.52.5PUT0 365.61FALSE00
2026-01-16403.2PUT0 21465.6FALSE00
2026-01-1642.54.1PUT5 4463.11FALSE4.10
2026-01-16455.7PUT0 1863.91FALSE00
2026-01-1647.55.9PUT0 460.41TRUE00
2026-01-16506.8PUT0 1457.93TRUE00
2026-01-1652.50PUT0 057.48TRUE00
2026-01-16550PUT0 054.33TRUE00
2026-01-1657.50PUT0 057.13TRUE00
2026-01-166013.2PUT0 1355.02TRUE00
2026-01-1662.50PUT0 054TRUE00
2026-01-16650PUT0 055.93TRUE00
2026-01-16700PUT0 254.82TRUE00
2026-01-16750PUT0 00TRUE00
2026-01-168035PUT0 10TRUE00
2026-01-16850PUT0 00TRUE00
2026-02-2022.50CALL0 073.01TRUE00
2026-02-20250CALL0 070.12TRUE00
2026-02-2027.50CALL0 068.55TRUE00
2026-02-20300CALL0 068.24TRUE00
2026-02-2032.50CALL0 067.5TRUE00
2026-02-20350CALL0 067.74TRUE00
2026-02-2037.50CALL0 067.35TRUE00
2026-02-20409CALL1 447.2TRUE90
2026-02-2042.56.41CALL0 10067.32TRUE00
2026-02-20456.1CALL0 465.36TRUE00
2026-02-2047.57.45CALL1 068.61FALSE7.450
2026-02-20503.9CALL0 859.65FALSE00
2026-02-2052.52.95CALL0 557.62FALSE00
2026-02-20559.8CALL0 149.05FALSE00
2026-02-2057.51.6CALL0 454.77FALSE00
2026-02-20602.2CALL0 2555.21FALSE00
2026-02-2062.50CALL0 075.6FALSE00
2026-02-20651.05CALL0 1375.17FALSE00
2026-02-20701.75CALL0 1076.87FALSE00
2026-02-20750CALL0 079.84FALSE00
2026-02-20800.35CALL0 1684.15FALSE00
2026-02-2022.50PUT0 0127.85FALSE00
2026-02-20250.95PUT0 4116.1FALSE00
2026-02-2027.51.25PUT0 4107.79FALSE00
2026-02-20301.5PUT0 3101.9FALSE00
2026-02-2032.50PUT0 096.37FALSE00
2026-02-20351.85PUT0 266.26FALSE00
2026-02-2037.50PUT0 064.38FALSE00
2026-02-20404.2PUT0 266.77FALSE00
2026-02-2042.54.8PUT0 563.46FALSE00
2026-02-20455.7PUT0 1165.61FALSE00
2026-02-2047.57.8PUT0 159.68TRUE00
2026-02-20508.5PUT0 862.46TRUE00
2026-02-2052.50PUT0 056.11TRUE00
2026-02-205511.6PUT0 653.83TRUE00
2026-02-2057.50PUT0 051.63TRUE00
2026-02-20600PUT0 049.53TRUE00
2026-02-2062.50PUT0 048.94TRUE00
2026-02-20650PUT0 048.46TRUE00
2026-02-20700PUT0 044.82TRUE00
2026-02-20750PUT0 00TRUE00
2026-02-20800PUT0 00TRUE00
2026-05-15250CALL0 064.63TRUE00
2026-05-1527.50CALL0 064.59TRUE00
2026-05-15300CALL0 065.57TRUE00
2026-05-1532.50CALL0 064.77TRUE00
2026-05-15350CALL0 064.86TRUE00
2026-05-1537.50CALL0 064.67TRUE00
2026-05-15400CALL0 063.88TRUE00
2026-05-1542.50CALL0 063.42TRUE00
2026-05-15450CALL0 062.53TRUE00
2026-05-1547.59.39CALL0 161.63FALSE00
2026-05-15500CALL0 060.76FALSE00
2026-05-1552.50CALL0 059.59FALSE00
2026-05-15550CALL0 058.49FALSE00
2026-05-1557.50CALL0 057.14FALSE00
2026-05-15600CALL0 056.08FALSE00
2026-05-15650CALL0 053.3FALSE00
2026-05-15700CALL0 069.64FALSE00
2026-05-15250PUT0 098.31FALSE00
2026-05-1527.50PUT0 093.05FALSE00
2026-05-15300PUT0 089.38FALSE00
2026-05-1532.50PUT0 063.31FALSE00
2026-05-15352.52PUT0 163.07FALSE00
2026-05-1537.50PUT0 062.8FALSE00
2026-05-15400PUT0 062.32FALSE00
2026-05-1542.50PUT0 061.89FALSE00
2026-05-15450PUT0 060.62FALSE00
2026-05-1547.50PUT0 060.39TRUE00
2026-05-15500PUT0 058.72TRUE00
2026-05-1552.50PUT0 057.39TRUE00
2026-05-15550PUT0 056.07TRUE00
2026-05-1557.50PUT0 054.77TRUE00
2026-05-15600PUT0 053.48TRUE00
2026-05-15650PUT0 051.49TRUE00
2026-05-15700PUT0 047.91TRUE00
2027-01-1522.50CALL0 067.04TRUE00
2027-01-15250CALL0 063.82TRUE00
2027-01-1527.50CALL0 065.06TRUE00
2027-01-15300CALL0 065.12TRUE00
2027-01-1532.50CALL0 064.41TRUE00
2027-01-15350CALL0 063.17TRUE00
2027-01-1537.50CALL0 061.53TRUE00
2027-01-15400CALL0 061.03TRUE00
2027-01-1542.50CALL0 060.1TRUE00
2027-01-15450CALL0 060.15TRUE00
2027-01-1547.50CALL0 059.8FALSE00
2027-01-15500CALL0 059.13FALSE00
2027-01-1552.50CALL0 058.15FALSE00
2027-01-15550CALL0 056.91FALSE00
2027-01-1557.50CALL0 057.81FALSE00
2027-01-15608.21CALL0 256.05FALSE00
2027-01-15655.95CALL0 154.21FALSE00
2027-01-15700CALL0 053.91FALSE00
2027-01-1522.50PUT0 0100.79FALSE00
2027-01-15250PUT0 090.1FALSE00
2027-01-1527.50PUT0 063.22FALSE00
2027-01-15303.15PUT0 260.25FALSE00
2027-01-1532.50PUT0 060.74FALSE00
2027-01-15355PUT0 160.42FALSE00
2027-01-1537.50PUT0 059.54FALSE00
2027-01-15400PUT0 058.2FALSE00
2027-01-1542.50PUT0 059.23FALSE00
2027-01-15450PUT0 057.09FALSE00
2027-01-1547.50PUT0 057.21TRUE00
2027-01-15500PUT0 056.93TRUE00
2027-01-1552.50PUT0 056.3TRUE00
2027-01-15550PUT0 055.35TRUE00
2027-01-1557.50PUT0 054.08TRUE00
2027-01-15600PUT0 054.95TRUE00
2027-01-15650PUT0 053.37TRUE00
2027-01-15700PUT0 053.25TRUE00
2028-01-2122.525.7CALL0 1065.34TRUE00
2028-01-21250CALL0 064.5TRUE00
2028-01-2127.50CALL0 064.88TRUE00
2028-01-21300CALL0 063.19TRUE00
2028-01-2132.50CALL0 061.34TRUE00
2028-01-21350CALL0 061.92TRUE00
2028-01-2137.50CALL0 062.1TRUE00
2028-01-21400CALL0 060.81TRUE00
2028-01-2142.50CALL0 059.38TRUE00
2028-01-21450CALL0 059.92TRUE00
2028-01-2147.50CALL0 059.19FALSE00
2028-01-21500CALL0 059.3FALSE00
2028-01-2152.50CALL0 058.26FALSE00
2028-01-21550CALL0 058.04FALSE00
2028-01-2157.50CALL0 057.68FALSE00
2028-01-21600CALL0 056.26FALSE00
2028-01-21650CALL0 056.75FALSE00
2028-01-21700CALL0 054.97FALSE00
2028-01-2122.50PUT0 061.43FALSE00
2028-01-21250PUT0 062.33FALSE00
2028-01-2127.50PUT0 059.14FALSE00
2028-01-21300PUT0 058.96FALSE00
2028-01-2132.50PUT0 058.32FALSE00
2028-01-21350PUT0 059.87FALSE00
2028-01-2137.50PUT0 058.49FALSE00
2028-01-21400PUT0 059.17FALSE00
2028-01-2142.50PUT0 057.34FALSE00
2028-01-21450PUT0 057.46FALSE00
2028-01-2147.50PUT0 057.32TRUE00
2028-01-21500PUT0 056.97TRUE00
2028-01-2152.50PUT0 056.41TRUE00
2028-01-21550PUT0 055.69TRUE00
2028-01-2157.50PUT0 054.81TRUE00
2028-01-21600PUT0 055.62TRUE00
2028-01-21650PUT0 054.86TRUE00
2028-01-21700PUT0 053.55TRUE00

Latest AKRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST22$8.07
Jun 13, 2022 7:59 PM EST11$8.07
Jun 13, 2022 7:59 PM EST14$8.06
Jun 13, 2022 7:59 PM EST10$8.07
Jun 13, 2022 7:59 PM EST47$8.07

Akero Therapeutics, Inc (AKRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-05-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1744659/000000000020004520/0000000000-20-004520-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000781/0000905148-20-000781-index.htm
2020-09-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820001009/0000905148-20-001009-index.htm
2020-05-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1744659/000091205720000169/0000912057-20-000169-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-07-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000104746920003964/0001047469-20-003964-index.htm
2020-07-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1744659/000104746920004044/0001047469-20-004044-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000108514620002410/0001085146-20-002410-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003240/0001104659-20-003240-index.htm
2020-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920020276/0001104659-20-020276-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920021077/0001104659-20-021077-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920025042/0001104659-20-025042-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033680/0001104659-20-033680-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034183/0001104659-20-034183-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920040850/0001104659-20-040850-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920051294/0001104659-20-051294-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920060866/0001104659-20-060866-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920066655/0001104659-20-066655-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920068978/0001104659-20-068978-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069071/0001104659-20-069071-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069072/0001104659-20-069072-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069074/0001104659-20-069074-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069075/0001104659-20-069075-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069077/0001104659-20-069077-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920071713/0001104659-20-071713-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072520/0001104659-20-072520-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072521/0001104659-20-072521-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920074004/0001104659-20-074004-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920078983/0001104659-20-078983-index.htm
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080872/0001104659-20-080872-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080873/0001104659-20-080873-index.htm
2020-07-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920081704/0001104659-20-081704-index.htm
2020-07-07S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1744659/000110465920081820/0001104659-20-081820-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082854/0001104659-20-082854-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082855/0001104659-20-082855-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-08-07RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920092022/0001104659-20-092022-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920093910/0001104659-20-093910-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920115114/0001104659-20-115114-index.htm
2020-01-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520008095/0001193125-20-008095-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000119312520028593/0001193125-20-028593-index.htm
2020-07-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520192675/0001193125-20-192675-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120008127/0001209191-20-008127-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000127417320000103/0001274173-20-000103-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1744659/000155837020002798/0001558370-20-002798-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020006498/0001558370-20-006498-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020010443/0001558370-20-010443-index.htm
2020-07-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1744659/999999999520001708/9999999995-20-001708-index.htm

Akero Therapeutics, Inc (AKRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akero Therapeutics, Inc (AKRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 840%
Institutional Ownership: 9380%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-09Kevin BittermanDirectorSell13,000.0028.93376,090.0011,780.00https://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy5,035.000.623,096.53177,518.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy6,082.000.623,740.43183,600.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy17,621.000.6210,836.92211,197.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-30G. Walmsley GrahamDirectorBuy2,168.0019.9743,294.962,168.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy27,368.000.6116,694.48220,277.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy21,286.000.6213,090.89232,483.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy22,656.000.6113,820.16242,933.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-07-06Global Strategic Fund II L.P. venBio10% Share HolderSell4,603.0033.83155,721.333,033,552.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-02Global Strategic Fund II L.P. venBio10% Share HolderSell3,800.0033.63127,805.403,038,155.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-01Global Strategic Fund II L.P. venBio10% Share HolderSell108,064.0034.453,723,010.123,041,955.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell17,849.0022.39399,639.113,092,698.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell8,091.0021.78176,221.983,110,547.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-17Versant Venture Capital VI, L.P.10% Share HolderSell11,103.0020.09223,059.273,118,638.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-16Versant Venture Capital VI, L.P.10% Share HolderSell22,489.0019.72443,483.083,129,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-03-06Global Strategic Fund II L.P. venBio10% Share HolderSell1,800.0023.7942,830.823,150,019.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-03-05Global Strategic Fund II L.P. venBio10% Share HolderSell8,500.0023.53200,010.953,151,819.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-15Versant Venture Capital VI, L.P.10% Share HolderSell7,511.0019.73148,192.033,152,230.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-14Versant Venture Capital VI, L.P.10% Share HolderSell12,307.0020.00246,140.003,159,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-04Global Strategic Fund II L.P. venBio10% Share HolderSell35,650.0023.81848,765.903,160,319.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell83.0020.841,729.723,172,048.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell11,593.0020.16233,714.883,172,131.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-10Versant Venture Capital VI, L.P.10% Share HolderSell19,343.0020.10388,794.303,183,724.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-03Global Strategic Fund II L.P. venBio10% Share HolderSell6,401.0023.00147,198.683,195,969.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-02Global Strategic Fund II L.P. venBio10% Share HolderSell10,297.0023.06237,459.123,202,370.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-09Versant Venture Capital VI, L.P.10% Share HolderSell16,527.0020.21334,010.673,203,067.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-28Global Strategic Fund II L.P. venBio10% Share HolderSell5,100.0021.30108,652.443,212,667.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-08Versant Venture Capital VI, L.P.10% Share HolderSell22,368.0019.80442,886.403,219,594.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-10Global Strategic Fund II L.P. venBio10% Share HolderSell7,836.0027.08212,168.323,225,861.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-27Global Strategic Fund II L.P. venBio10% Share HolderSell1,781.0022.5440,143.743,227,767.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-26Global Strategic Fund II L.P. venBio10% Share HolderSell2,523.0022.4456,615.363,229,548.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-25Global Strategic Fund II L.P. venBio10% Share HolderSell1,600.0023.6737,876.003,232,071.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-12Global Strategic Fund II L.P. venBio10% Share HolderSell6.0027.14162.843,233,671.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-11Global Strategic Fund II L.P. venBio10% Share HolderSell2,184.0027.0559,068.033,233,677.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-06Global Strategic Fund II L.P. venBio10% Share HolderSell6,102.0027.03164,954.763,233,697.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-05Global Strategic Fund II L.P. venBio10% Share HolderSell28,608.0025.99743,547.673,239,799.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-07Versant Venture Capital VI, L.P.10% Share HolderSell14,162.0020.05283,948.103,241,962.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell42,323.0019.93843,497.393,256,124.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-02-04Global Strategic Fund II L.P. venBio10% Share HolderSell53,731.0025.651,378,178.663,268,407.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell6,101.0018.32111,770.323,298,447.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell4,968.0017.6887,834.243,304,548.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell100.0020.272,027.003,309,516.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell3,100.0019.1859,458.003,309,616.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-13Global Strategic Fund II L.P. venBio10% Share HolderSell494,000.0020.239,993,620.003,322,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-01-08Global Strategic Fund II L.P. venBio10% Share HolderSell15,677.0019.86311,354.633,816,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-07Global Strategic Fund II L.P. venBio10% Share HolderSell31,000.0020.17625,149.103,831,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-06Global Strategic Fund II L.P. venBio10% Share HolderSell42,221.0019.64829,380.883,862,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-03Global Strategic Fund II L.P. venBio10% Share HolderSell12,498.0019.30241,213.903,905,036.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Global Strategic Fund II L.P. venBio10% Share HolderSell23,000.0019.94458,507.303,917,534.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell1,000.0022.1722,170.003,996,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell3,900.0021.2082,680.003,997,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell10,952.0019.89217,835.284,001,759.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-07-10Apple Tree Partners IV, L.P.10% Share HolderBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-07-10Seth Loring HarrisonDirectorBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm